Showing 1 - 20 results of 54,482 for search '(((( 50 ((a decrease) OR (_ decrease)) ) OR ( i ex decrease ))) OR ( 12 m decrease ))*', query time: 1.23s Refine Results
  1. 1
  2. 2

    <i>roh</i> mutation results in Rh1 decrease. by Yu Huang (15093)

    Published 2015
    “…<p>(A) GFP fluorescence of one-day old wild-type (left panel) and <i>roh</i><sup><i>EY04039</i></sup> (right panel) flies showing a reduction in Rh1-GFP. …”
  3. 3

    CCCP decreased TMRE signals in <i>ex vivo</i> perfused hearts. by Akira Kawamoto (444329)

    Published 2015
    “…(B) Representative images of TMRE signals. Scale bar: 50μm. (C) CCCP decreased the TMRE signals of perfused hearts in a dose-dependent manner 20 min after CCCP perfusion (n = 3–4 per group). …”
  4. 4
  5. 5
  6. 6

    Bioluminescence decreased following <i>ex vivo</i> collagenase digestion of transgenic femora. by Sarah E. Mailhiot (766685)

    Published 2015
    “…<p>Femora from tamoxifen treated transgenic mice were degraded in collagenase. (A) The femur showed a linear decrease (r = -0.619, p = 0.0452) after 6 hours in digestion. …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

    Published 2021
    “…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

    Published 2019
    “…CHPG, α-amino-2-chloro-5-hydroxybenzeneacetic acid; DHPG, (S)-3,5-Dihydroxyphenylglycine; GABA<sub>A</sub> receptor, γ-Aminobutyric acid type A receptor; GDP-β-S, Guanosine 5ʹ-O-(2-Thiodiphosphate); GlyR, glycine receptor; IPSC, inhibitory postsynaptic current; mGluR5, metabotropic glutamate receptor 5; MPEP, 6-Methyl-2-(phenylethynyl) pyridine; PD98059, 2ʹ-Amino-3ʹ-methoxyflavone; Ro-32-0432, 2-{8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-3-yl}-3-(1-methyl-1H-indol-3-yl)maleimide.…”
  20. 20